Skip to content

From lab bench to convention booth and beyond: Atlantic biosciences industry takes Boston by storm

42 organizations promote region’s products and innovation at BIO International Convention

Atlantic Canada’s bioscience innovation ecosystem is booming. The industry’s recent and rapid growth has given rise to new companies, more jobs and is reflected in an important shift in perspective about Atlantic Canada. Key strategic infrastructure developments are leading to advances in research, products, and skills development, capturing the attention of domestic and international markets and partners. The swift nature of this progress is spurring the region’s economic momentum and leadership in the bio manufacturing and life sciences industries.

Yesterday, 42 Atlantic Canadian companies, research organizations, institutions and industry associations concluded a four-day trip to Boston, Massachusetts, where they attended the BIO International Convention (BIO 2023) and showcased the best that Atlantic Canada has to offer when it comes to biosciences products and services.

The trip came at a perfect time for participating delegates, with the recent publication of the Atlantic Canada Momentum Index already creating buzz over Atlantic Canada as a place to prosper, grow and settle. Atlantic Canada is gaining attention as a global leader in start-up ecosystems, ocean tech, biomanufacturing and aerospace.

While in Boston, the Atlantic Candian delegation showcased a sample of the region’s leading products and innovations in biosciences, life sciences, pharmaceutical technology and biomanufacturing. The conference facilitated networking opportunities on workforce development and training, as well as connected members of the Atlantic Canadian delegation with key international players.

The industry and trade relationships built and strengthened at BIO 2023 will help accelerate the region’s outstanding momentum and enhance Atlantic Canada’s economic resiliency by creating new opportunities to drive high-value products and services.

Quotes:

“Once again this year, the region’s biosciences industry demonstrated they have earned their place as leaders in the global innovation ecosystem at Bio 2023. The Atlantic Canada delegation successfully showcased new initiatives in research, innovation, skills and training, and infrastructure within the region that are helping to advance Canada’s Biomanufacturing and Life Sciences Strategy. Our strong presence at the conference is a testament to the achievements and capabilities of the bioscience industry in Atlantic Canada, and ACOA is proud to support these outreach and growth opportunities for our region.”

  • The Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for ACOA

 “The Atlantic Canadian delegation to BIO 2023 successfully highlighted new initiatives in research, innovation, skills and training and infrastructure in the region that are advancing Canada’s Biomanufacturing and Life Sciences Strategy. Our strong presence at the conference is a testament to the achievements and capabilities of the bioscience industry in Atlantic Canada.”

  •  Rory Francis, CEO, Prince Edward Island BioAlliance

From lab bench to convention booth and beyond: Atlantic biosciences industry takes Boston by storm

42 organizations promote region’s products and innovation at BIO International Convention

From the Atlantic Canada Opportunities Agency newsroom:

Atlantic Canada’s bioscience innovation ecosystem is booming. The industry’s recent and rapid growth has given rise to new companies, more jobs and is reflected in an important shift in perspective about Atlantic Canada. Key strategic infrastructure developments are leading to advances in research, products, and skills development, capturing the attention of domestic and international markets and partners. The swift nature of this progress is spurring the region’s economic momentum and leadership in the bio manufacturing and life sciences industries.

Yesterday, 42 Atlantic Canadian companies, research organizations, institutions and industry associations concluded a four-day trip to Boston, Massachusetts, where they attended the BIO International Convention (BIO 2023) and showcased the best that Atlantic Canada has to offer when it comes to biosciences products and services.

The trip came at a perfect time for participating delegates, with the recent publication of the Atlantic Canada Momentum Index already creating buzz over Atlantic Canada as a place to prosper, grow and settle. Atlantic Canada is gaining attention as a global leader in start-up ecosystems, ocean tech, biomanufacturing and aerospace.

While in Boston, the Atlantic Candian delegation showcased a sample of the region’s leading products and innovations in biosciences, life sciences, pharmaceutical technology and biomanufacturing. The conference facilitated networking opportunities on workforce development and training, as well as connected members of the Atlantic Canadian delegation with key international players.

The industry and trade relationships built and strengthened at BIO 2023 will help accelerate the region’s outstanding momentum and enhance Atlantic Canada’s economic resiliency by creating new opportunities to drive high-value products and services.

Quotes:

“Once again this year, the region’s biosciences industry demonstrated they have earned their place as leaders in the global innovation ecosystem at Bio 2023. The Atlantic Canada delegation successfully showcased new initiatives in research, innovation, skills and training, and infrastructure within the region that are helping to advance Canada’s Biomanufacturing and Life Sciences Strategy. Our strong presence at the conference is a testament to the achievements and capabilities of the bioscience industry in Atlantic Canada, and ACOA is proud to support these outreach and growth opportunities for our region.”

  • The Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for ACOA

 “The Atlantic Canadian delegation to BIO 2023 successfully highlighted new initiatives in research, innovation, skills and training and infrastructure in the region that are advancing Canada’s Biomanufacturing and Life Sciences Strategy. Our strong presence at the conference is a testament to the achievements and capabilities of the bioscience industry in Atlantic Canada.”

  •  Rory Francis, CEO, Prince Edward Island BioAlliance

RPS Biologiques receives Health Canada notifications for latest fish health product

Emergence client and PEI bioscience cluster company RPS Biologiques Inc. has announced that its latest Veterinary Health Product (VHP), Puralyze™, recently received two notification numbers from Health Canada’s Veterinary Drugs Directorate (VDD). Puralyze™ received approval in both liquid and powdered forms allowing this novel natural product to be marketed and sold in Canada.

RPS Biologiques develops innovative biotech products with proven market potential. In 2019, the company’s natural product Supratect™ became the first VHP notified by Health Canada for use in aquatic species; an exceptional milestone that paved the way for future technologies to further enrich the  aquaculture industry with new, innovative products.

Read full story on the RPS Biologiques website.

National Growth Expands Canada’s Food & Agri-Tech Engine

GUELPH, Ontario–(BUSINESS WIRE)–New partnerships, collaborations and services across Canada are continuing the drive to unite the country’s fragmented agriculture and agri-food innovation system. As Canada’s Food & Agri-Tech Engine, Bioenterprise now boasts a growing national network of connected regional and provincial partners, an expanding team of 10 innovation advisors across Canada, and seven innovation locations stretching from Atlantic Canada to British Columbia. “It’s long been ou

Triumvira Appoints Teresa McRoberts as Chief Financial Officer and Announces Senior Level Promotions

AUSTIN, Texas & HAMILTON, Ontario–(BUSINESS WIRE)–Triumvira Immunologics (“Triumvira” or the “Company”), a privately held biopharmaceutical company developing a novel platform for engineering T cells to attack cancers, today announced the appointment of Teresa McRoberts as Chief Financial Officer. The Company also announced the promotion of Andreas Bader, Ph.D. to Chief Scientific Officer and Jon Irvin to Senior Vice President of Finance. “We are pleased to welcome Teresa to our management te

NICE Renews Support for Use of AI-powered HeartFlow Analysis in Heart Disease Diagnosis

REDWOOD CITY, Calif.–(BUSINESS WIRE)–HeartFlow, Inc., a leader in revolutionizing precision heartcare, today announced that the National Institute of Health and Care Excellence (NICE) has renewed its support for the use of its AI-powered HeartFlow® FFRct Analysis to fight coronary heart disease (CHD), one of the leading causes of death in the UK. NICE has found that the HeartFlow Analysis continues to improve patient experience and reduce the need for invasive angiography, four years after it

It can happen here

Charlottetown-based Cannabis and help oil extraction company has clients around the world and is looking to expand. Read more in this article by Terrence McEachern in The Guardian Newspaper.

Scroll To Top